Ida Gjervold Lunde

  • Head of Oslo-CCHR Lab, Professor; PhD, FESC
  • +47 905 11 364

Personal home page at UiO

Education

  • PhD (2008-2012), Faculty of Medicine, University of Oslo
  • MSc (2001-2006), Molecular Biology, University of Oslo

Work record (selected)

  • Head of Oslo-CCHR (2023-), Department of Cardiology Ullevaal, Oslo University Hospital
  • Professor II (2023-), Institute for Clinical Medicine, University of Oslo
  • Research Leader (2021-2023), Division of Diagnostics and Technology (DDT), Akershus University Hospital
  • Research Group Leader (2017-2022), Institute for Experimental Medical Research (IEMR), Oslo University Hospital
  • Postdoc (2013-2015), Seidman Lab, Department of Genetics, Harvard Medical School, Boston 
  • Postdoc (2012-2013 and 2015-2017), Institute for Experimental Medical Research (IEMR), Oslo University Hospital 

Awards, committees, memberships

  • Fellow of the European Society of Cardiology (ESC), FESC lifelong title awarded by the ESC.
  • Several international and national awards, incl. Young Investigator Award (YIA) at the European Society of Cardiology (ESC; 2010, 2012, 2013) and His Majesty the King of Norway’s Gold Medal for Young Researchers (2012).
  • Selected/elected member of several research committees, incl. Committee on Translational Research of the Heart Failure Association(HFA) of the European Society of Cardiology (ESC) (2014-2018), Nucleus member of the Working Group of Myocardial Function of the ESC (2020 – ), leader group of the Norwegian PhD School of Heart Research (NORHEART, 2013-2021), Cardiovascular Board of Nasjonalforeningen (2018- ).

Other

  • Teaching, examination, supervision and mentoring activities. 
  • Research communication at meetings and conferences, and public outreach. 
  • Funding from Research Council of Norway incl. Personal Postdoc and Young Research Talents, K. G. Jebsen (K.G. Jebsen Center for Cardiac Biomarkers 2022-2027), Nasjonalforeningen, Simon Fougner Hartmann, Ullevålfondet, G M Raagholt`s Fond, Blix Fond, Fondsstiftelsen, Horizon 2020 Framework Program of the EU: COST Action (EU-METAHEART 2023-).

Research Areas

  • Genetic cardiology
  • Cardiac fibrosis
  • Heart failure
  • Proteoglycans
  • Titin